Alkermes plc. Operating Income
Alkermes plc. (ALKS) reported Operating Income of $18.35 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-28
- Alkermes plc. operating income (loss) for the quarter ending 2026-06-30 was $18.35M, a 80.26% decline year-over-year.
- Alkermes plc. operating income (loss) for the quarter ending 2026-03-31 was -$48.28M, a 450.06% decline year-over-year.
- Alkermes plc. operating income (loss) for the quarter ending 2025-12-31 was $58.10M, a 64.29% decline year-over-year.
- Alkermes plc. operating income (loss) for the quarter ending 2025-09-30 was $89.08M, a 14.96% decline year-over-year.
- Alkermes plc. operating income (loss) for fiscal 2025 was $253.96M, a 39.63% decline from fiscal 2024.
- Alkermes plc. operating income (loss) for fiscal 2024 was $420.64M, a 1.57% increase from fiscal 2023.
- Alkermes plc. operating income (loss) for fiscal 2023 was $414.12M.
- Alkermes plc. operating income (loss) for fiscal 2022 was -$6.09M, a 106.23% decline from fiscal 2021.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $18.35M 10-Q · filed 2026-07-28 | -$29.93M 10-Q · filed 2026-07-28 | $28.18M derived: sum of 3 quarters · filed 2026-07-28 | $117.26M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2026-03-31 | -$48.28M 10-Q · filed 2026-05-05 | $9.82M derived: sum of 2 quarters · filed 2026-05-05 | $98.91M derived: sum of 3 quarters · filed 2026-05-05 | $191.88M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-12-31 | $58.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $147.19M derived: sum of 2 quarters · filed 2026-02-25 | $240.16M derived: sum of 3 quarters · filed 2026-07-28 | $253.96M 10-K · filed 2026-02-25 | ||||
| 2025-09-30 | $89.08M 10-Q · filed 2025-10-28 | $182.06M derived: sum of 2 quarters · filed 2026-07-28 | $195.85M 10-Q · filed 2025-10-28 | $358.54M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-06-30 | $92.98M 10-Q · filed 2026-07-28 | $106.77M 10-Q · filed 2026-07-28 | $269.46M derived: sum of 3 quarters · filed 2026-07-28 | $374.21M derived: sum of 4 quarters · filed 2026-07-28 | ||||
| 2025-03-31 | $13.79M 10-Q · filed 2026-05-05 | $176.48M derived: sum of 2 quarters · filed 2026-05-05 | $281.24M derived: sum of 3 quarters · filed 2026-05-05 | $391.12M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | $162.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $267.44M derived: sum of 2 quarters · filed 2026-02-25 | $377.33M derived: sum of 3 quarters · filed 2026-02-25 | $420.64M 10-K · filed 2026-02-25 | ||||
| 2024-09-30 | $104.76M 10-Q · filed 2025-10-28 | $214.64M derived: sum of 2 quarters · filed 2025-10-28 | $257.95M 10-Q · filed 2025-10-28 | $312.58M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-06-30 | $109.88M 10-Q · filed 2025-07-29 | $153.19M 10-Q · filed 2025-07-29 | $207.82M derived: sum of 3 quarters · filed 2026-02-25 | $297.02M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2024-03-31 | $43.31M 10-Q · filed 2025-05-01 | $97.94M derived: sum of 2 quarters · filed 2026-02-25 | $187.13M derived: sum of 3 quarters · filed 2026-02-25 | $468.40M derived: sum of 4 quarters · filed 2026-02-25 | ||||
| 2023-12-31 | $54.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $143.82M derived: sum of 2 quarters · filed 2026-02-25 | $425.09M derived: sum of 3 quarters · filed 2026-02-25 | $414.12M 10-K · filed 2026-02-25 | ||||
| 2023-09-30 | $89.19M 10-Q · filed 2024-10-24 | $43.85M 10-Q · filed 2023-10-25 | $370.46M derived: sum of 2 quarters · filed 2024-10-24 | $359.49M 10-Q · filed 2024-10-24 | $235.55M 10-Q · filed 2023-10-25 | $475.08M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-06-30 | $281.27M 10-Q · filed 2024-07-24 | $239.19M 10-Q · filed 2023-07-26 | $270.30M 10-Q · filed 2024-07-24 | $191.70M 10-Q · filed 2023-07-26 | $385.89M derived: sum of 3 quarters · filed 2025-02-12 | $325.25M derived: sum of 4 quarters · filed 2025-02-12 | ||
| 2023-03-31 | -$10.97M 10-Q · filed 2024-05-01 | -$47.49M 10-Q · filed 2023-04-26 | $104.62M derived: sum of 2 quarters · filed 2025-02-12 | $43.98M derived: sum of 3 quarters · filed 2025-02-12 | $9.52M derived: sum of 4 quarters · filed 2025-02-12 | |||
| 2022-12-31 | $115.59M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | $54.95M derived: sum of 2 quarters · filed 2025-02-12 | $20.50M derived: sum of 3 quarters · filed 2025-02-12 | -$6.09M 10-K · filed 2025-02-12 | -$142.26M 10-K · filed 2023-02-16 | |||
| 2022-09-30 | -$60.64M 10-Q · filed 2023-10-25 | -$95.10M derived: sum of 2 quarters · filed 2023-10-25 | -$121.68M 10-Q · filed 2023-10-25 | $7.73M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | -$34.46M 10-Q · filed 2023-07-26 | -$61.04M 10-Q · filed 2023-07-26 | $68.37M derived: sum of 3 quarters · filed 2024-02-21 | $48.72M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | -$26.59M 10-Q · filed 2023-04-26 | $102.83M derived: sum of 2 quarters · filed 2024-02-21 | $83.17M derived: sum of 3 quarters · filed 2024-02-21 | $87.59M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | $129.42M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | $109.76M derived: sum of 2 quarters · filed 2024-02-21 | $114.18M derived: sum of 3 quarters · filed 2024-02-21 | $97.75M 10-K · filed 2024-02-21 | -$29.29M 10-K · filed 2022-02-16 | |||
| 2021-09-30 | -$19.66M 10-Q · filed 2022-11-02 | -$15.24M derived: sum of 2 quarters · filed 2022-11-02 | -$31.67M 10-Q · filed 2022-11-02 | -$62.40M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-06-30 | $4.42M 10-Q · filed 2022-07-27 | -$12.01M 10-Q · filed 2022-07-27 | -$42.74M derived: sum of 3 quarters · filed 2023-02-16 | -$53.41M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2021-03-31 | -$16.43M 10-Q · filed 2022-04-27 | -$47.16M derived: sum of 2 quarters · filed 2023-02-16 | -$57.83M derived: sum of 3 quarters · filed 2023-02-16 | -$91.49M derived: sum of 4 quarters · filed 2023-02-16 | ||||
| 2020-12-31 | -$30.73M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$41.40M derived: sum of 2 quarters · filed 2023-02-16 | -$75.06M derived: sum of 3 quarters · filed 2023-02-16 | -$112.43M 10-K · filed 2023-02-16 | ||||
| 2020-09-30 | -$10.67M 10-Q · filed 2021-10-27 | -$44.33M derived: sum of 2 quarters · filed 2021-10-27 | -$81.70M 10-Q · filed 2021-10-27 | -$91.63M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$33.66M 10-Q · filed 2021-07-28 | -$71.03M 10-Q · filed 2021-07-28 | -$80.97M derived: sum of 3 quarters · filed 2022-02-16 | -$134.59M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | -$37.37M 10-Q · filed 2021-04-28 | -$47.30M derived: sum of 2 quarters · filed 2022-02-16 | -$100.92M derived: sum of 3 quarters · filed 2022-02-16 | -$136.85M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | -$9.93M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$63.55M derived: sum of 2 quarters · filed 2022-02-16 | -$99.48M derived: sum of 3 quarters · filed 2022-02-16 | -$175.48M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | -$53.62M 10-Q · filed 2020-10-29 | -$89.54M derived: sum of 2 quarters · filed 2020-10-29 | -$165.54M 10-Q · filed 2020-10-29 | -$165.53M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-06-30 | -$35.92M 10-Q · filed 2020-07-29 | -$111.92M 10-Q · filed 2020-07-29 | -$111.90M derived: sum of 3 quarters · filed 2021-02-11 | -$149.06M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2019-03-31 | -$76.00M 10-Q · filed 2020-04-29 | -$75.98M derived: sum of 2 quarters · filed 2021-02-11 | -$113.14M derived: sum of 3 quarters · filed 2021-02-11 | -$113.24M derived: sum of 4 quarters · filed 2021-02-11 | ||||
| 2018-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$37.14M derived: sum of 2 quarters · filed 2021-02-11 | -$37.24M derived: sum of 3 quarters · filed 2021-02-11 | -$99.13M 10-K · filed 2021-02-11 | ||||
| 2018-09-30 | -$37.16M 10-Q · filed 2019-10-23 | -$37.26M derived: sum of 2 quarters · filed 2019-10-23 | -$99.15M 10-Q · filed 2019-10-23 | -$93.31M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-06-30 | -$102.00K 10-Q · filed 2019-07-25 | -$61.99M 10-Q · filed 2019-07-25 | -$56.16M derived: sum of 3 quarters · filed 2020-02-13 | -$94.51M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2018-03-31 | -$61.89M 10-Q · filed 2019-04-25 | -$56.05M derived: sum of 2 quarters · filed 2020-02-13 | -$94.41M derived: sum of 3 quarters · filed 2020-02-13 | -$138.92M derived: sum of 4 quarters · filed 2020-02-13 | ||||
| 2017-12-31 | $5.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$32.52M derived: sum of 2 quarters · filed 2020-02-13 | -$77.03M derived: sum of 3 quarters · filed 2020-02-13 | -$147.90M 10-K · filed 2020-02-13 | ||||
| 2017-09-30 | -$38.36M 10-Q · filed 2018-10-23 | -$82.86M derived: sum of 2 quarters · filed 2018-10-23 | -$153.74M 10-Q · filed 2018-10-23 | -$177.27M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-06-30 | -$44.51M 10-Q · filed 2018-07-26 | -$115.38M 10-Q · filed 2018-07-26 | -$138.92M derived: sum of 3 quarters · filed 2019-02-15 | -$200.04M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2017-03-31 | -$70.87M 10-Q · filed 2018-04-26 | -$94.41M derived: sum of 2 quarters · filed 2019-02-15 | -$155.53M derived: sum of 3 quarters · filed 2019-02-15 | -$202.65M derived: sum of 4 quarters · filed 2019-02-15 | ||||
| 2016-12-31 | -$23.54M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-15 | -$84.66M derived: sum of 2 quarters · filed 2019-02-15 | -$131.78M derived: sum of 3 quarters · filed 2019-02-15 | -$208.66M 10-K · filed 2019-02-15 | ||||
| 2016-09-30 | -$61.13M 10-Q · filed 2017-10-26 | -$108.24M derived: sum of 2 quarters · filed 2017-10-26 | -$185.13M 10-Q · filed 2017-10-26 | -$252.19M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-06-30 | -$47.12M 10-Q · filed 2017-07-27 | -$124.00M 10-Q · filed 2017-07-27 | -$191.06M derived: sum of 3 quarters · filed 2018-02-16 | -$268.47M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2016-03-31 | -$76.88M 10-Q · filed 2017-04-27 | -$143.94M derived: sum of 2 quarters · filed 2018-02-16 | -$221.36M derived: sum of 3 quarters · filed 2018-02-16 | -$273.88M derived: sum of 4 quarters · filed 2018-02-16 | ||||
| 2015-12-31 | -$67.06M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$144.47M derived: sum of 2 quarters · filed 2018-02-16 | -$196.99M derived: sum of 3 quarters · filed 2018-02-16 | -$224.30M 10-K · filed 2018-02-16 | ||||
| 2015-09-30 | -$77.42M 10-Q · filed 2016-11-02 | -$129.94M derived: sum of 2 quarters · filed 2016-11-02 | -$157.24M 10-Q · filed 2016-11-02 | -$172.93M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | -$52.52M 10-Q · filed 2016-07-28 | -$79.83M 10-Q · filed 2016-07-28 | -$95.52M derived: sum of 3 quarters · filed 2017-02-17 | -$128.25M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | -$27.31M 10-Q · filed 2016-04-28 | -$43.00M derived: sum of 2 quarters · filed 2017-02-17 | -$75.73M derived: sum of 3 quarters · filed 2017-02-17 | -$98.56M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | -$15.69M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$48.43M derived: sum of 2 quarters · filed 2017-02-17 | -$71.25M derived: sum of 3 quarters · filed 2017-02-17 | -$87.14M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | -$32.74M 10-Q · filed 2015-10-29 | -$55.56M derived: sum of 2 quarters · filed 2015-10-29 | -$71.46M 10-Q · filed 2015-10-29 | -$65.61M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-06-30 | -$22.82M 10-Q · filed 2015-07-30 | -$38.72M 10-Q · filed 2015-07-30 | -$32.88M derived: sum of 3 quarters · filed 2016-02-25 | -$36.75M derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2014-03-31 | -$15.89M 10-Q · filed 2015-04-30 | -$10.05M derived: sum of 2 quarters · filed 2016-02-25 | -$13.93M derived: sum of 3 quarters · filed 2016-02-25 | -$399.00K derived: sum of 4 quarters · filed 2016-02-25 | ||||
| 2013-12-31 | $5.84M derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | $1.97M derived: sum of 2 quarters · filed 2016-02-25 | $15.49M 10-K · filed 2016-02-25 | $34.48M 10-K · filed 2016-02-25 | ||||
| 2013-09-30 | -$3.88M 10-Q · filed 2014-10-29 | $9.65M 10-Q · filed 2013-10-31 | $28.63M 10-Q · filed 2014-10-29 | $53.90M derived: sum of 4 quarters · filed 2014-10-29 | ||||
| 2013-06-30 | $13.53M 10-Q · filed 2014-07-31 | $32.51M 10-Q · filed 2014-07-31 | $57.77M derived: sum of 3 quarters · filed 2014-07-31 | $63.20M derived: sum of 4 quarters · filed 2014-07-31 | ||||
| 2013-03-31 | $18.98M 10-Q · filed 2014-04-30 | $44.24M derived: sum of 2 quarters · filed 2014-04-30 | $49.67M derived: sum of 3 quarters · filed 2014-04-30 | $81.81M 10-K · filed 2015-02-24 | ||||
| 2012-12-31 | $25.26M 10-Q · filed 2013-01-31 | $30.68M derived: sum of 2 quarters · filed 2013-10-31 | $62.83M 10-K · filed 2015-02-24 | $5.16M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-09-30 | $5.42M 10-Q · filed 2013-10-31 | $37.57M 10-Q · filed 2013-10-31 | -$20.10M derived: sum of 3 quarters · filed 2014-02-27 | -$25.07M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-06-30 | $32.15M 10-Q · filed 2013-07-25 | -$25.52M derived: sum of 2 quarters · filed 2014-02-27 | -$30.49M derived: sum of 3 quarters · filed 2014-02-27 | -$42.25M derived: sum of 4 quarters · filed 2014-02-27 | ||||
| 2012-03-31 | -$57.67M derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | -$62.63M derived: sum of 2 quarters · filed 2014-02-27 | -$74.40M derived: sum of 3 quarters · filed 2014-02-27 | -$88.28M 10-KT · filed 2014-02-27 | ||||
| 2011-12-31 | -$4.97M 10-Q · filed 2013-01-31 | -$16.73M derived: sum of 2 quarters · filed 2013-01-31 | -$30.61M 10-Q · filed 2013-01-31 | -$44.22M derived: sum of 4 quarters · filed 2013-05-23 | ||||
| 2011-09-30 | -$11.76M 10-Q · filed 2012-11-01 | -$25.65M 10-Q · filed 2012-11-01 | -$39.25M derived: sum of 3 quarters · filed 2013-05-23 | -$51.16M derived: sum of 4 quarters · filed 2013-05-23 | ||||
| 2011-06-30 | -$13.88M 10-Q · filed 2012-07-26 | -$27.48M derived: sum of 2 quarters · filed 2013-05-23 | -$39.39M derived: sum of 3 quarters · filed 2013-05-23 | -$46.43M derived: sum of 4 quarters · filed 2013-05-23 | ||||
| 2011-03-31 | -$13.60M derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-23 | -$25.51M derived: sum of 2 quarters · filed 2013-05-23 | -$32.54M derived: sum of 3 quarters · filed 2013-05-23 | -$45.63M 10-K · filed 2013-05-23 | ||||
| 2010-12-31 | -$11.91M 10-Q · filed 2012-02-02 | -$18.94M derived: sum of 2 quarters · filed 2012-02-02 | -$32.03M 10-Q · filed 2012-02-02 | |||||
| 2010-09-30 | -$7.03M 10-Q · filed 2011-11-03 | -$20.12M 10-Q · filed 2011-11-03 | ||||||
| 2010-03-31 | -$43.03M 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |